Recent studies have identified new melanoma antigens that are recognised by CD4(+) T cells. Analysis of tumour-specific CD4(+) T-cell responses may lead to the development of optimal anti-cancer vaccines that can induce an orchestrated effort of tumour-specific CD4(+) and CD8(+) T cells in the fight against cancer.
机构:
Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
Parker Inst Canc Immunotherapy, San Francisco, CA USAStanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
Meier, Stefanie L.
Satpathy, Ansuman T.
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
Parker Inst Canc Immunotherapy, San Francisco, CA USAStanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
Satpathy, Ansuman T.
Wells, Daniel K.
论文数: 0引用数: 0
h-index: 0
机构:
Immunai, New York, NY 10014 USAStanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA